These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7979285)

  • 1. Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.
    Jacobson MA; Gallant J; Wang LH; Coakley D; Weller S; Gary D; Squires L; Smiley ML; Blum MR; Feinberg J
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1534-40. PubMed ID: 7979285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valaciclovir (BW256U87): the L-valyl ester of acyclovir.
    Jacobson MA
    J Med Virol; 1993; Suppl 1():150-3. PubMed ID: 8245883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy.
    Wang LH; Schultz M; Weller S; Smiley ML; Blum MR
    Antimicrob Agents Chemother; 1996 Jan; 40(1):80-5. PubMed ID: 8787884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers.
    Weller S; Blum MR; Doucette M; Burnette T; Cederberg DM; de Miranda P; Smiley ML
    Clin Pharmacol Ther; 1993 Dec; 54(6):595-605. PubMed ID: 8275615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans.
    Soul-Lawton J; Seaber E; On N; Wootton R; Rolan P; Posner J
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2759-64. PubMed ID: 8593015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
    Beutner KR; Friedman DJ; Forszpaniak C; Andersen PL; Wood MJ
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1546-53. PubMed ID: 7492102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of interaction between valaciclovir, the L-valyl ester of acyclovir, and Maalox antacid.
    de Bony F; Bidault R; Peck R; Posner J
    J Antimicrob Chemother; 1996 Feb; 37(2):383-7. PubMed ID: 8707752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness.
    Simon MW; Fish DN; Deeter RG
    Drugs R D; 2002; 3(6):365-73. PubMed ID: 12516939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
    Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of interaction between valaciclovir, the L-valyl ester of aciclovir, and digoxin.
    Soul-Lawton JH; Weatherley BC; Posner J; Layton G; Peck RW
    Br J Clin Pharmacol; 1998 Jan; 45(1):87-9. PubMed ID: 9489600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Faulds D
    Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
    Feinberg JE; Hurwitz S; Cooper D; Sattler FR; MacGregor RR; Powderly W; Holland GN; Griffiths PD; Pollard RB; Youle M; Gill MJ; Holland FJ; Power ME; Owens S; Coakley D; Fry J; Jacobson MA
    J Infect Dis; 1998 Jan; 177(1):48-56. PubMed ID: 9419169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.
    Colin J; Prisant O; Cochener B; Lescale O; Rolland B; Hoang-Xuan T
    Ophthalmology; 2000 Aug; 107(8):1507-11. PubMed ID: 10919899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.
    Fife KH; Barbarash RA; Rudolph T; Degregorio B; Roth R
    Sex Transm Dis; 1997 Sep; 24(8):481-6. PubMed ID: 9293612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.
    Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG
    Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects.
    Gimenez F; Foeillet E; Bourdon O; Weller S; Garret C; Bidault R; Singlas E
    Clin Pharmacokinet; 2004; 43(10):685-92. PubMed ID: 15244498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.
    Bodsworth NJ; Crooks RJ; Borelli S; Vejlsgaard G; Paavonen J; Worm AM; Uexkull N; Esmann J; Strand A; Ingamells AJ; Gibb A
    Genitourin Med; 1997 Apr; 73(2):110-6. PubMed ID: 9215092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients.
    Höglund M; Ljungman P; Weller S
    J Antimicrob Chemother; 2001 Jun; 47(6):855-61. PubMed ID: 11389118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
    Johnston C; Saracino M; Kuntz S; Magaret A; Selke S; Huang ML; Schiffer JT; Koelle DM; Corey L; Wald A
    Lancet; 2012 Feb; 379(9816):641-7. PubMed ID: 22225814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.